Atrial flutter: A focus on treatment options for a common supraventricular tachyarrhythmia

Journal of Cardiovascular Medicine

Volumn 8, Issue 8, 2007, Pages 558-567

  Andrew, Peter ^a   Montenero, Annibale S ^b  

^a aATLAS Medical Research Inc   (Canada)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

Arrhythmia; Atrial flutter; Catheter ablation; Cavotricuspid isthmus; Cryoablation; Radiofrequency catheter ablation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DOFETILIDE; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; QUINIDINE; SOTALOL;

CARDIOVERSION; CATHETER ABLATION; CLINICAL PRACTICE; CLINICAL TRIAL; EXTRASYSTOLE; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HUMAN; REENTRY ARRHYTHMIA; REVIEW; RISK BENEFIT ANALYSIS; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; HEART CONDUCTION SYSTEM; HUMANS; PATIENT SELECTION; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 34547762239     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000281711.89422.d0     Document Type: Review

References (80)

1. Lee KW, Yang Y, Scheinman MM. Atrial flutter: a review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol 2005; 30:121-167.
2. Wellens HJ. Contemporary management of atrial flutter. Circulation 2002; 106:649-652.
3. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, Tieleman RG, Crijns HJ. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 1999; 84:147R-151R.
4. Trohman RG, Parrillo JE. Direct current cardioversion: indications, techniques, and recent advances. Crit Care Med 2000; 28 (Suppl):N170-N173.
5. Waldo AL. Treatment of atrial flutter. Heart 2000; 84:227-232.
6. Houghton T, Kaye GC. Implantable devices for treating tachyarrhythmias. BMJ 2003; 327:333-336.
7. Israel CW, Barold SS. Failure of atrial flutter detection by a pacemaker with a dedicated atrial flutter detection algorithm. Pacing Clin Electrophysiol 2002; 25:1274-1277.
8. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004; 44:2362-2367.
9. Goethals M, Timmermans W, Geelen P, Backers J, Brugada P. Mode switching failure during atrial flutter: the '2 : 1 lock-in' phenomenon. Europace 2003; 5:95-102.
10. Volkmann H, Dannberg G, Heinke M, Kuhnert H. Termination of tachycardias by transesophageal electrical pacing. Pacing Clin Electrophysiol 1992; 15 (Pt 2):1962-1966.
11. Disertori M. Transesophageal atrial stimulation in the treatment of atrial flutter. Its usefulness and limits. G Ital Cardiol 1993; 23:281-283.
12. Ajisaka H, Hiraki T, Ikeda H, Kubara I, Yoshida T, Ohga M, et al. Direct conversion of atrial flutter to sinus rhythm with low-output, short-duration transesophageal atrial pacing. Clin Cardiol 1997; 20:762-766.
13. Sun JL, Guo JH, Zhang N, Zhang HC, Zhang P. Clinical comparison of ibutilide and propafenone for converting atrial flutter. Cardiovasc Drugs Ther 2005; 19:57-64.
14. Reisinger J, Gatterer E, Lang W, Vanicek T, Eisserer G, Bachleitner T, et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J 2004; 25:1318-1324.
15. Purerfellner H. Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond. Curr Med Chem Cardiovasc Hematol Agents 2004; 2:79-91.
16. Khan MH. Oral class III antiarrhythmics: what is new? Curr Opin Cardiol 2004; 19:47-51.
17. Yamreudeewong W, DeBisschop M, Martin LG, Lower DL. Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Saf 2003; 26:421-438.
18. Wooten JM, Earnest J, Reyes J. Review of common adverse effects of selected antiarrhythmic drugs. Crit Care Nurs Q 2000; 22:23-38.
19. Nemec J, Shen WK. Antiarrhythmic drugs: new agents and evolving concepts. Expert Opin Investig Drugs 2003; 12:435-453.
20. Tai CT, Chen SA. Mechanisms of antiarrhythmic drug action on termination of atrial flutter. Pacing Clin Electrophysiol 2001; 24:824-834.
21. Foldesi C, Pandozi C, Peichl P, Bulava A, Castro A, Lamberti F, et al. Atrial flutter: arrhythmia circuit and basis for radiofrequency catheter ablation. Ital Heart J 2003; 4:395-403.
22. Yee R, Connolly S, Noorani H. Clinical review of radiofrequency catheter ablation for cardiac arrhythmias. Can J Cardiol 2003; 19:1273-1284.
23. Feld GK. Radiofrequency ablation of atrial flutter using large-tip electrode catheters. J Cardiovasc Electrophysiol 2004; 15 (Suppl):S18-S23.
24. Feld G, Wharton M, Plumb V, Daoud E, Friehling T, Epstein L, for the EPT-1000 XP Cardiac Ablation System Investigators. Radiofrequency catheter ablation of type 1 atrial flutter using large-tip 8- or 10-mm electrode catheters and a high-output radiofrequency energy generator: results of a multicenter safety and efficacy study. J Am Coll Cardiol 2004; 43:1466-1472.
25. Montenero AS, Bruno N, Antonelli A, Mangiameli D, Barbieri L, Zumbo F, et al. Low clinical recurrence and procedure benefits following treatment of common atrial flutter by electrogram-guided hot spot focal cryoablation. J Interv Card Electrophysiol 2006; 15:83-92.
26. Natale A, Newby KH, Pisano E, Leonelli F, Fanelli R, Potenza D, et al. Prospective randomized comparison of antiarrhythmic therapy versus firstline radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35:1898-1904.
27. Marrouche NF, Schweikert R, Saliba W, Pavia SV, Martin DO, Dresing T, et al. Use of different catheter ablation technologies for treatment of typical atrial flutter: acute results and long-term follow-up. Pacing Clin Electrophysiol 2003; 26:743-746.
28. Montenero AS, Bruno N, Antonelli A, Mangiameli D, Murphy O, O'Connor S, et al. Safety and efficacy of catheter cryoablation for the treatment of atrial flutter: acute and long-term results. Ital Heart J 2004; 5 (Suppl 1):131S-137S.
29. Manusama R, Timmermans C, Limon F, Philippens S, Crijns HJ, Rodriguez LM. Catheter-based cryoablation permanently cures patients with common atrial flutter. Circulation 2004; 109:1636-1639.
30. Nakagawa H, McClelland J, Beckman K, Wang X, Lazzara R, Hazlitt A, et al. Radiofrequency catheter ablation of common type atrial flutter [abstract]. Pacing Clin Electrophysiol 1993; 16:850.
31. Fischer B, Jais P, Shah D, Chouairi S, Haissaguerre M, Garrigues S, et al. Radiofrequency catheter ablation of common atrial flutter in 200 patients. J Cardiovasc Electrophysiol 1996; 7:1225-1233.
32. Montenero AS, Bruno N, Antonelli A, Mangiameli D, Barbieri L, Andrew P, et al. Long-term efficacy of cryo catheter ablation for the treatment of atrial flutter: results from a repeat electrophysiologic study. J Am Coll Cardiol 2005; 45:573-580.
33. Montenero AS, Bruno N, Antonelli A, Mangiameli D, Barbieri L, Andrew P, et al. Comparison between a 7 French 6mm tip cryothermal catheter and a 9 French 8mm tip cryothermal catheter for cryoablation treatment of common atrial flutter. J Interv Card Electrophysiol 2005; 13:59-69.
34. Calkins H, Canby R, Weiss R, Taylor G, Wells P, Chinitz L, et al. Results of catheter ablation of typical atrial flutter. Am J Cardiol 2004; 94:437-442.
35. Tracy CM, Akhtar M, DiMarco JP, Packer DL, Weitz HH, Winters WL, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on invasive electrophysiology studies, catheter ablation, and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Circulation 2000; 102:2309-2320.
36. Garcia-Cosio F, Pastor A, Nunez A. Radiofrequency ablation as the first line of treatment in patients with common atrial flutter. The arguments con. Rev Esp Cardiol 1999; 52:233-236.
37. Cosio FG. Should ablation be the first line treatment for supraventricular arrhythmias? Heart 2005; 91:5-6.
38. Bertaglia E, Zoppo F, Bonso A, Proclemer A, Verlato R, Coro L, et al. Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart 2004; 90:59-63.
39. De Sisti A, Leclercq JF, Fiorello P, Palamara A, Attuel P. The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation. G Ital Cardiol 1998; 28:1253-1260.
40. Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider MA, et al. Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J 2003; 24:956-962.
41. Anne W, Willems R, Adriaenssens B, Adams J, Ector H, Heidbuchel H. Long-term symptomatic benefit after radiofrequency catheter ablation for atrial flutter despite a high incidence of post-procedural atrial fibrillation. Acta Cardiol 2006; 61:75-82.
42. Della BP, Fraticelli A, Tondo C, Riva S, Fassini G, Carbucicchio C. Atypical atrial flutter: clinical features, electrophysiological characteristics and response to radiofrequency catheter ablation. Europace 2002; 4:241-253.
43. Cheng CH, Sanders GD, Hlatky MA, Heidenreich P, McDonald KM, Lee BK, et al. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 2000; 133:864-876.
44. Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 1998; 82:589-593.
45. Da Costa A, Romeyer-Bouchard C, Zarqane-Sliman N, Messier M, Samuel B, Kihel A, et al. Impact of first line radiofrequency ablation in patients with lone atrial flutter on the long term risk of subsequent atrial fibrillation. Heart 2005; 91:97-98.
46. Hall B, Veerareddy S, Cheung P, Good E, Lemola K, Han J, et al. Randomized comparison of anatomical versus voltage guided ablation of the cavotricuspid isthmus for atrial flutter. Heart Rhythm 2004; 1:43-48.
47. Feld GK. Radiofrequency catheter ablation of type 1 atrial flutter using a large-tip electrode catheter and high-power radiofrequency energy generator. Expert Rev Med Devices 2004; 1:187-192.
48. Timmermans C, Ayers GM, Crijns HJ, Rodriguez LM. Randomized study comparing radiofrequency ablation with cryoablation for the treatment of atrial flutter with emphasis on pain perception. Circulation 2003; 107:1250-1252.
49. Schreieck J, Zrenner B, Kumpmann J, Ndrepepa G, Schneider MA, Deisenhofer I, et al. Prospective randomized comparison of closed cooledtip versus 8-mm-tip catheters for radiofrequency ablation of typical atrial flutter. J Cardiovasc Electrophysiol 2002; 13:980-985.
50. Spitzer SG, Karolyi L, Rammler C, Otto T. Primary closed cooled tip ablation of typical atrial flutter in comparison to conventional radiofrequency ablation. Europace 2002; 4:265-271.
51. Simpson CS, Mitchell LB, Klein GJ. Similarities and differences between atrial flutter and atrial fibrillation. Can J Cardiol 2005; 21 (Suppl B):67B-70B.
52. Gilligan DM, Zakaib JS, Fuller I, Shepard RK, Dan D, Wood MA, et al. Long-term outcome of patients after successful radiofrequency ablation for typical atrial flutter. Pacing Clin Electrophysiol 2003; 26 (Pt 1):53-58.
53. Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 1995; 92:673-691.
54. Lee DS, Dorian P, Downar E, Burns M, Yeo EL, Gold WL, et al. Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation? Europace 2001; 3:195-200.
55. Zhou L, Keane D, Reed G, Ruskin J. Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J Cardiovasc Electrophysiol 1999; 10:611-620.
56. Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000; 23:1020-1028.
57. Ventura R, Willems S, Weiss C, Flecke J, Risius T, Rostock T, et al. Large tip electrodes for successful elimination of atrial flutter resistant to conventional catheter ablation. J Interv Card Electrophysiol 2003; 8:149-154.
58. Tsai CF, Tai CT, Yu WC, Chen YJ, Hsieh MH, Chiang CE, et al. Is 8-mm more effective than 4-mm tip electrode catheter for ablation of typical atrial flutter? Circulation 1999; 100:768-771.
59. Rodriguez LM, Nabar A, Timmermans C, Wellens HJ. Comparison of results of an 8-mm split-tip versus a 4-mm tip ablation catheter to perform radiofrequency ablation of type I atrial flutter. Am J Cardiol 2000; 85:109-112.
60. Hsieh MH, Tai CT, Chiang CE, Tsai CF, Yu WC, Chen YJ, et al. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J Interv Card Electrophysiol 2002; 7:225-231.
61. Laurent G, De Chillou C, Bertaux G, Poull IM, Martel A, Andronache M, et al. Simple and efficient identification of conduction gaps in post-ablation recurring atrial flutters. Europace 2006; 8:7-15.
62. Starek Z, Zaoral L, Leinveber P, Haman L, Csanadi Z, Herman D. Can we cure atrial flutter with radiofrequency ablation in an hour? Vnitr Lek 2006; 52:132-136.
63. Montenero AS, Bruno N, Zumbo F, Antonelli A, Fiocca L, Barbieri L, et al. Cryothermal ablation treatment of atrial flutter - experience with a new 9 French 8mm tip catheter. J Interv Card Electrophysiol 2005; 12:45-54.
64. Manusama R, Timmermans C, Philippens S, Crijns HJ, Ayers GM, Rodriguez LM. Single cryothermia applications of less than five minutes produce permanent cavotricuspid isthmus block in humans. Heart Rhythm 2004; 1:594-599.
65. Rodriguez LM, Geller JC, Tse HF, Timmermans C, Reek S, Lee KL, et al. Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia). J Cardiovasc Electrophysiol 2002; 13:1082-1089.
66. Collins NJ, Barlow M, Varghese P, Leitch J. Cryoablation versus Radiofrequency Ablation in the Treatment of Atrial Flutter Trial (CRAAFT). J Interv Card Electrophysiol 2006; 16:1-5.
67. Daubert JP, Hoyt RH, John R, Chinitz L, Martin DT, Fellows C, et al. Performance of a new cardiac cryoablation system in the treatment of cavotricuspid valve isthmus-dependent atrial flutter. Pacing Clin Electrophysiol 2005; 28 (Suppl 1):S142-S145.
68. Friedman PL. Catheter cryoablation of cardiac arrhythmias. Curr Opin Cardiol 2005; 20:48-54.
69. Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003; 107:2045-2050.
70. Kuniss M, Kurzidim K, Greiss H, Berkowitsch A, Sperzel J, Hamm C, et al. Acute success and persistence of bidirectional conduction block in the cavotricuspid isthmus one month post cryocatheter ablation of common atrial flutter. Pacing Clin Electrophysiol 2006; 29:146-152.
71. Lowe MD, Meara M, Mason J, Grace AA, Murgatroyd FD. Catheter cryoablation of supraventricular arrhythmias: a painless alternative to radiofrequency energy. Pacing Clin Electrophysiol 2003; 26 (Pt 2):500-503.
72. Rodriguez LM, Timmermans C. Transvenous cryoablation of cardiac arrhythmias. Technol Cancer Res Treat 2004; 3:515-524.
73. Skanes AC, Yee R, Krahn AD, Klein GJ. Cryoablation of atrial arrhythmias. Card Electrophysiol Rev 2002; 6:383-388.
74. Skanes AC, Klein G, Krahn A, Yee R. Cryoablation: potentials and pitfalls. J Cardiovasc Electrophysiol 2004; 15 (Suppl):S28-S34.
75. Van Oeveren W, Crijns HJ, Korteling BJ, Wegereef EW, Haan J, Tigchelaar I, et al. Blood damage, platelet and clotting activation during application of radiofrequency or cryoablation catheters: a comparative in vitro study. J Med Eng Technol 1999; 23:20-25.
76. Laurent G, Bertaux G, Martel A, Fraison M, Fromentin S, Gonzalez S, et al. A randomized clinical trial of continuous flow nitrous oxide and nalbuphine infusion for sedation of patients during radiofrequency atrial flutter ablation. Pacing Clin Electrophysiol 2006; 29:351-357.
77. Anselme F, Savoure A. Catheter ablation as the first line therapy for symptomatic typical atrial flutter: a multicenter randomized study of cost-effectiveness. http://www.ClinicalTrials.gov [Accessed 19 January 2007].
78. Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Luderitz B. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol 1999; 83:710-713.
79. Hirao K, Okishige K, Yamamoto N, Otomo K, Azegami K, Isobe M. Longterm efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter. Clin Cardiol 2005; 28:338-342.
80. Montenero AS, Andrew P. Current treatment options for atrial flutter and results with cryocatheter ablation. Expert Rev Cardiovasc Ther 2006; 4:191-202.